PubRank

P L Bruijnzeel

Author PubWeight™ 41.77‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 T cell subsets and their soluble products regulate eosinophilia in allergic and nonallergic asthma. J Immunol 1991 1.98
2 IL-4 controls the selective endothelium-driven transmigration of eosinophils from allergic individuals. J Immunol 1992 1.47
3 Sputum eosinophils from asthmatics express ICAM-1 and HLA-DR. Clin Exp Immunol 1991 1.30
4 An improved method for the isolation of eosinophilic granulocytes from peripheral blood of normal individuals. J Leukoc Biol 1988 1.23
5 Pharmacological effects of oximes: how relevant are they? Arch Toxicol 1996 1.15
6 Modulation and induction of eosinophil chemotaxis by granulocyte-macrophage colony-stimulating factor and interleukin-3. Blood 1991 1.11
7 Allergen presentation by epidermal Langerhans' cells from patients with atopic dermatitis is mediated by IgE. Immunology 1990 1.08
8 Migration of primed human eosinophils across cytokine-activated endothelial cell monolayers. Blood 1992 1.07
9 Upregulation of formyl-peptide and interleukin-8-induced eosinophil chemotaxis in patients with allergic asthma. J Allergy Clin Immunol 1993 1.06
10 IL-4-induced migration of eosinophils in allergic inflammation. Ann N Y Acad Sci 1994 1.02
11 Modulation of eosinophil chemotaxis by interleukin-5. Am J Respir Cell Mol Biol 1992 1.00
12 In vivo priming of platelet-activating factor-induced eosinophil chemotaxis in allergic asthmatic individuals. Blood 1992 0.98
13 Interleukin-4 induces tissue eosinophilia in mice: correlation with its in vitro capacity to stimulate the endothelial cell-dependent selective transmigration of human eosinophils. J Lab Clin Med 1993 0.97
14 Intratracheal aerosolization of endotoxin (LPS) in the rat: a comprehensive animal model to study adult (acute) respiratory distress syndrome. Exp Lung Res 1997 0.95
15 Pathogenesis of skin lesions in mice with chronic proliferative dermatitis (cpdm/cpdm). Am J Pathol 1996 0.91
16 Human platelets secrete chemotactic activity for eosinophils. Blood 1993 0.88
17 Maintenance of donor phenotype after full-thickness skin transplantation from mice with chronic proliferative dermatitis (cpdm/cpdm) to C57BL/Ka and nude mice and vice versa. J Invest Dermatol 1995 0.87
18 Effects of immunosuppressive treatment on the in vitro activity of mouse lymphoid cells after stimulation by PHA and allogeneic cells. Int Arch Allergy Appl Immunol 1973 0.86
19 An automated method for registering and quantifying scratching activity in mice: use for drug evaluation. J Pharmacol Toxicol Methods 2001 0.84
20 Dermal absorption of polycyclic aromatic hydrocarbons in the blood-perfused pig ear. J Appl Toxicol 1995 0.83
21 Human eosinophils constitutively express a functional interleukin-4 receptor: interleukin-4 -induced priming of chemotactic responses and induction of PI-3 kinase activity. Am J Respir Cell Mol Biol 1998 0.83
22 Increased expression of CD11b and functional changes in eosinophils after migration across endothelial cell monolayers. J Immunol 1993 0.82
23 The eosinophilic granulocyte an active participant in the late phase asthmatic reaction? Bull Eur Physiopathol Respir 1986 0.82
24 IL-4 induces chemotaxis of blood eosinophils from atopic dermatitis patients, but not from normal individuals. J Invest Dermatol 1994 0.81
25 The Langerhans cell: an underestimated cell in atopic disease. Clin Exp Allergy 1990 0.80
26 The presence of IgE molecules on epidermal Langerhans cells in atopic dermatitis and their significance for its pathogenesis. Allerg Immunol (Paris) 1989 0.80
27 Therapeutic interventions in mice with chronic proliferative dermatitis (cpdm/cpdm). Exp Dermatol 2000 0.80
28 Desensitization of the beta-adrenergic receptor on leucocytes after long-term oral use of a beta-sympathicomimetic; its effect on the beta-adrenergic blockade hypothesis of Szentivanyi. Ann Allergy 1979 0.79
29 Mast cell heterogeneity in human lung tissue. Clin Sci (Lond) 1989 0.79
30 Efficacy of Curosurf in a rat model of acute respiratory distress syndrome. Eur Respir J 1998 0.79
31 Beneficial effects of TCP on soman intoxication in guinea pigs: seizures, brain damage and learning behaviour. J Appl Toxicol 2001 0.79
32 Behavioral test systems in marmoset monkeys. Behav Res Methods Instrum Comput 2000 0.79
33 Blood lymphocyte subpopulations in extrinsic and intrinsic asthmatics. Ann Allergy 1987 0.79
34 Differential effects of the T helper cell type 2-derived cytokines IL-4 and IL-5 on ligand binding to IgG and IgA receptors expressed by human eosinophils. J Immunol 1997 0.78
35 T cells and asthma. II. Regulation of the eosinophilia of asthma by T cell cytokines. Int Arch Allergy Appl Immunol 1991 0.78
36 Evaluation of variables influencing the outcome of the atopy patch test. J Allergy Clin Immunol 1995 0.77
37 Scopolamine augments the efficacy of physostigmine against soman poisoning in guinea pigs. Pharmacol Biochem Behav 2000 0.77
38 New aspects in the pathogenesis of atopic dermatitis. Acta Derm Venereol Suppl (Stockh) 1989 0.77
39 Role of Langerhans cells in atopic disease. Int Arch Allergy Appl Immunol 1989 0.77
40 Clinical and immunologic variables in skin of patients with atopic eczema and either positive or negative atopy patch test reactions. J Allergy Clin Immunol 2000 0.77
41 Evaluation of the atopy patch test and the cutaneous late-phase reaction as relevant models for the study of allergic inflammation in patients with atopic eczema. J Allergy Clin Immunol 1996 0.77
42 Leukotriene C4 formation by enriched human basophil preparations from normal and asthmatic subjects. Prostaglandins Leukot Essent Fatty Acids 1991 0.77
43 Increased sensitivity of the chemoattractant-induced chemiluminescence in eosinophils isolated from atopic individuals. Immunology 1989 0.77
44 Subchronic physostigmine pretreatment in guinea pigs: effective against soman and without side effects. Pharmacol Biochem Behav 1998 0.77
45 An immunochemical assay to detect DNA damage in bovine sperm. J Androl 2000 0.76
46 Inhibition of cytokine-primed eosinophil chemotaxis by nedocromil sodium. J Allergy Clin Immunol 1993 0.75
47 T cells and asthma. I. Lymphocyte subpopulations and activation in allergic and nonallergic asthma. Int Arch Allergy Appl Immunol 1991 0.75
48 Mast cell subtypes from human lung tissue: their identification, separation, and functional characteristics. Agents Actions 1988 0.75
49 The isolation of inflammatory cells from normal human lung tissue. Int J Tissue React 1987 0.75
50 Nedocromil sodium inhibits the early and late asthmatic response to exercise. Eur Respir J 1992 0.75
51 [When is desensitization with bee and wasp venoms indicated in children?]. Ned Tijdschr Geneeskd 1984 0.75
52 Non-reactivating effects of HI-6 on hippocampal neurotransmission. Arch Toxicol 1994 0.75
53 New generic approach to the treatment of organophosphate poisoning: adenosine receptor mediated inhibition of ACh-release. Drug Chem Toxicol 1998 0.75
54 The rate of percutaneous permeation of xylene, measured using the "perfused pig ear" model, is dependent on the effective protein concentration in the perfusing medium. Toxicol Appl Pharmacol 1994 0.75
55 Subchronic physostigmine pretreatment in marmosets: absence of side effects and effectiveness against soman poisoning with negligible postintoxication incapacitation. Toxicol Sci 2000 0.75
56 Modulation of the atopy patch test reaction by topical corticosteroids and tar. J Allergy Clin Immunol 2000 0.75
57 The isolation of human lung mast cells by affinity chromatography. Scand J Immunol 1988 0.75